Long‐term human IgG treatment improves heart and muscle function in a mouse model of Duchenne muscular dystrophy

BACKGROUND: Duchenne muscular dystrophy (DMD) is a progressive muscle‐wasting disease caused by mutations in the dystrophin gene, which leads to structural instability of the dystrophin–glycoprotein‐complex with subsequent muscle degeneration. In addition, muscle inflammation has been implicated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zschüntzsch, Jana, Jouvenal, Pia Vanessa, Zhang, Yaxin, Klinker, Florian, Tiburcy, Malte, Liebetanz, David, Malzahn, Dörthe, Brinkmeier, Heinrich, Schmidt, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432639/
https://www.ncbi.nlm.nih.gov/pubmed/32436338
http://dx.doi.org/10.1002/jcsm.12569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432639/
https://www.ncbi.nlm.nih.gov/pubmed/32436338
http://dx.doi.org/10.1002/jcsm.12569

Ejemplares similares